<DOC>
	<DOCNO>NCT02156609</DOCNO>
	<brief_summary>The HeartMate PHP catheter-based pump design provide partial left heart circulatory support . The study assess safety performance HeartMate PHP support patient hemodynamically unstable , risk hemodynamically unstable , undergo percutaneous coronary intervention ( PCI ) , coronary stent placement .</brief_summary>
	<brief_title>HeartMate PHP™ CE Mark Clinical Investigation Plan</brief_title>
	<detailed_description>The HeartMate PHP ( percutaneous heart pump ) catheter-based axial flow pump design provide partial leave ventricular circulatory support . The primary objective prospective , nonrandomized , multi-center , open-label trial ass safety performance HeartMate PHP support patient hemodynamically unstable , risk hemodynamically unstable , undergo percutaneous coronary intervention ( PCI ) .</detailed_description>
	<criteria>At least 18 year age . Patient present nonemergent need complex PCI : 1. ejection fraction ≤35 % require hemodynamic support procedure , AND 2. heart team determine patient optimal surgical candidate , OR patient elect undergo surgery Written , sign , date informed consent Emergent PCI ST elevation myocardial infarction within 7 day procedure Cardiac arrest within 7 day procedure require CPR defibrillation Hemodynamic support HeartMate PHP postPCI anticipate Cardiogenic shock ( SBP &lt; 90 mmHg &gt; 1 hour either cool clammy skin OR oliguria OR alter sensorium OR cardiac index &lt; 2.2 L/min/m2 ) Mural thrombus leave ventricle History aortic valve replacement Documented presence aortic stenosis ( orifice area 1.5cm2 less ) Moderate severe aortic insufficiency ( echocardiographic assessment aortic insufficiency grade 2 high ) Severe peripheral vascular disease Abnormalities aorta would preclude surgery , include aneurysm significant tortuosity calcification Planned use rotablator atherectomy procedure Serum creatinine &gt; 3.5mg/dL within 7 day procedure Liver dysfunction elevation liver enzymes bilirubin level ≥ 3x ULN INR ( Internationalized Normalized Ratio ) ≥2 Uncorrectable abnormal coagulation parameter Active systemic infection require treatment antibiotic Clinically relevant stroke TIA within 3 month procedure . Patients suspect stroke TIA within 3 month procedure must document absence neurological infarction Uncontrollable allergy intolerance heparin , aspirin , clopidogrel , ionic nonionic contrast medium , potentially required anticoagulant antiplatelet therapy drug History heparin induce thrombocytopenia Patient pregnant planning become pregnant study period Participation another clinical study investigational drug device meet primary endpoint</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>HeartMate PHP</keyword>
	<keyword>HeartMate PHP CE Mark</keyword>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>PCI</keyword>
	<keyword>Percutaneous ventricular assist</keyword>
	<keyword>Thoratec Corporation</keyword>
</DOC>